Pazopanib in the management of advanced soft tissue sarcomas
Lee D Cranmer,1 Elizabeth T Loggers,2 Seth M Pollack2 1Division of Medical Oncology, University of Washington, Seattle, WA, USA; 2Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Abstract: Therapy of soft tissue sarcomas represents an area of significant unmet n...
Main Authors: | Cranmer LD, Loggers ET, Pollack SM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-06-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/pazopanib-in-the-management-of-advanced-soft-tissue-sarcomas-peer-reviewed-article-TCRM |
Similar Items
-
The role of Pazopanib in Soft Tissue Sarcoma: A comprehensive review of the literature
by: Fotopoulos George, et al.
Published: (2015-09-01) -
Pneumothorax during Pazopanib Treatment in Patients with Soft-Tissue Sarcoma: Two Case Reports and a Review of the Literature
by: Yoshiro Nakahara, et al.
Published: (2017-04-01) -
Treatment-related adverse effects with pazopanib, sorafenib and sunitinib in patients with advanced soft tissue sarcoma: a pooled analysis
by: Que Y, et al.
Published: (2018-07-01) -
Metastatic Alveolar Soft Part Sarcoma Responsive to Pazopanib after Progression through Sunitinib and Bevacizumab: Two Cases
by: William L. Read, et al.
Published: (2016-10-01) -
Key Advances in the Systemic Therapy for Soft tissue Sarcomas: Current Status and Future Directions
by: Neelesh Soman, et al.
Published: (2013-10-01)